Posts

UVA-led discovery challenges 30-year-old dogma in assoc...

A University of Virginia-led study about a class of materials called associative...

BRAIN LOGISTICS: Missing link explains mRNA delivery in...

Faraway, so close! Credit: Schuhmacher et al. (2023) / MPI-CBG Faraway, so close...

Multiple sclerosis more prevalent in Black Americans th...

Multiple sclerosis has traditionally been considered a condition that predominan...

Subtle signs of fluctuations in critical point search

UPTON, NY—Physicists analyzing data from gold ion smashups at the Relativistic H...

Results of SWOG S1929 trial show patients with small-ce...

Among patients with extensive stage small-cell lung cancer (SCLC) that is positi...

Scientific publishers and funding agencies unite in fav...

Making the research ecosystem more diverse and inclusive has been, in recent yea...

UC Davis C-STEM trains Redlands teachers on bringing co...

Twenty-five teachers from Redlands Unified School District in southern Californi...

Startups to unveil cutting-edge point-of-care technolog...

June 2, 2023 Credit: JODIE ANDRUSKEVICH PHOTO June 2, 2023   Contact: Emily Gowd...

New working group of the GRC is tasked with facilitatin...

Producing the knowledge needed to achieve the Sustainable Development Goals (SDG...

ASCO: Targeted therapy induces responses in HER2-amplif...

ABSTRACT: 4008 Credit: MD Anderson Cancer Center ABSTRACT: 4008 CHICAGO ― HER2-t...

For advanced, HER2-amplified bile duct cancers, antibod...

Bile duct cancers are uncommon and aggressive types of gastrointestinal cancer. ...

Aridis receives FDA agreement on single Phase 3 study f...

Aridis Pharmaceuticals, Inc. received encouraging FDA feedback on their planned ...

Eli Lilly and Novo Nordisk Compete in the Obesity Drug ...

Eli Lilly and Novo Nordisk, two major players in the pharmaceutical industry, ar...

Sanofi’s frexalimab shows early potential in in Phase I...

The anti-CD 40L antibody was associated with a a significant reduction in lesion...

AstraZeneca and MSD’s Lynparza combo bags FDA approval ...

The approval is for the use of Lynparza in combination with Zytiga and prednison...

Pneumagen raises £8 million for further study of intran...

The Scottish company raised further funding to fuel an upcoming Phase IIb study ...